Clinical outcomes and prognostic factors of volumetric modulated arc therapy (VMAT) of esophageal cancer
Definitive radiotherapy of 60Gy with VMAT is feasible and safe for patients with esophageal cancer. Pre-treatment NLR >3 was an independent prognostic factor for OS.
Authors
- Tatsuya Mikami (ORCID: https://orcid.org/0000-0002-6657-6446)
- Akitomo Sugawara
- Takeshi Akiba
- Yuri Toyoda
- Ryuta Nagao
- S. Kabuki (ORCID: https://orcid.org/0000-0002-6931-090X)
- Tsuyoshi Takazawa
- Toshihisa Kuroki (ORCID: https://orcid.org/0000-0003-1380-7981)
- Yoshitsugu Matsumoto (ORCID: https://orcid.org/0000-0003-2871-2758)
- Tsuyoshi Fukuzawa
- Yoji Nakano
Institutions
- Tokai University (JP)
- Tokai University Hachioji Hospital (JP)
Publication Details
- Journal
- Reports of Practical Oncology & Radiotherapy
- Published
- 2024-08-09
- DOI
- https://doi.org/10.5603/rpor.101529
- Primary Topic
- Medical Imaging Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00